FDA, as expected, rejects Lilly and Innovent immunotherapy in a signal to drugmakers
March 24, 2022Sun Pharma forks over $485M to settle long-running legal battle inherited in Ranbaxy buyout
March 24, 2022At least nine biotechs working in cell or gene therapy have announced layoffs, cost cuts or restructured their research since December — restructurings that have coincided with a stock market downturn.
